AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Global IBD Market: Industry Analysis, Size, Share, Growth, Trends & Forecast, 2019-2027 - ResearchAndMarkets.com

February 12, 2020 GMT

DUBLIN--(BUSINESS WIRE)--Feb 12, 2020--

The “IBD - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027” report has been added to ResearchAndMarkets.com’s offering.

IBD (Ulcerative Colitis and Crohn’s Disease) Treatment Market - Scope of the Report

The report on the global IBD (ulcerative colitis and Crohn’s disease) treatment market studies the past as well as current growth trends and opportunities to gain valuable insights of the same indicators for the said market for the forecast period of 2019 to 2027. The report provides the overall market revenue of the global IBD (ulcerative colitis and Crohn’s disease) treatment market for the period of 2017-2027, considering 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global IBD treatment market for the forecast period.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study. Additionally, the report sheds light on the changing competitive dynamics in the global IBD (ulcerative colitis and Crohn’s disease) treatment market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the global IBD treatment market. The next section of the global IBD (ulcerative colitis and Crohn’s disease) treatment report highlights the USPs, which include disease prevalence: IBD (ulcerative colitis and Crohn’s disease) globally, IBD (ulcerative colitis and Crohn’s disease) treatment pipeline analysis, and major deals and strategic alliances analysis in the global IBD (ulcerative colitis and Crohn’s disease) treatment market.

Key Questions Answered in Global IBD (Ulcerative Colitis and Crohn’s Disease) Treatment Market Report

Global IBD Treatment Market - Research Objectives and Research Approach

The comprehensive report on the global IBD (ulcerative colitis and Crohn’s disease) treatment market begins with an overview of the said market, followed by the scope and objectives of the study. Following this, the report provides detailed explanation of the objectives of this study and healthcare compliances laid down by accredited agencies in the purview of research in the global IBD (ulcerative colitis and Crohn’s disease) treatment market. It is followed by a market introduction, market dynamics, and an overview of the global IBD treatment market, which includes an analysis of the market drivers, restraints, and trends affecting the growth of the market. Furthermore, Y-o-Y analysis with elaborate insights have been provided to understand the Y-o-Y trends of the IBD (ulcerative colitis and Crohn’s disease) treatment market. The next section of the global IBD (ulcerative colitis and Crohn’s disease) treatment report highlights the USPs, including disease prevalence, globally, treatment pipeline analysis, and major deals & strategic alliance analysis in the global IBD (ulcerative colitis and Crohn’s disease) treatment market.

Key Topics Covered:

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global IBD (Ulcerative Colitis and Crohn’s Disease) Treatment Market

4. Market Overview

4.1. Introduction

4.2. Key Industry Developments

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.4. Global IBD (Ulcerative Colitis and Crohn’s Disease) Treatment Market Value (US$ Mn) Forecast, 2017-2027

5. Global IBD (Ulcerative Colitis and Crohn’s Disease) Treatment Market, Key Insights

5.1. Clinical Trial Pipeline Analysis: IBD (Ulcerative Colitis & Crohn’s Disease) Treatment Market

5.2. Disease Prevalence: IBD (Ulcerative Colitis & Crohn’s Disease) Treatment Market

5.3. Major Deals & Strategic Alliances Analysis: IBD (Ulcerative Colitis & Crohn’s Disease) Treatment Market

6. Global IBD (Ulcerative Colitis and Crohn’s Disease) Treatment Market Analysis and Forecast, by Drug Class

6.1. Key Findings

6.2. Introduction

6.3. Market Value (US$ Mn) Forecast, by Drug Class, 2019-2027

6.3.1. TNF Inhibitors

6.3.2. Aminosalicylates

6.3.3. Integrin Antagonists

6.3.4. Corticosteroids

6.3.5. Others

6.4. Market Attractiveness Analysis, by Drug Class

7. Global IBD (Ulcerative Colitis and Crohn’s Disease) Treatment Market Analysis and Forecasts, by Disease Indication

7.1. Key Findings

7.2. Introduction

7.3. Market Value (US$ Mn) Forecast, by Disease Indication, 2019-2027

7.3.1. Ulcerative Colitis

7.3.2. Crohn’s Disease

7.4. Market Attractiveness Analysis, by Disease Indication

8. Global IBD (Ulcerative Colitis and Crohn’s Disease) Treatment Market Analysis and Forecasts, by Distribution Channel

8.1. Key Findings

8.2. Introduction

8.3. Market Value (US$ Mn) Forecast by Distribution Channel, 2019-2027

8.3.1. Hospital Pharmacies

8.3.2. Retail Pharmacies

8.3.3. Online Pharmacies

8.4. Market Attractiveness Analysis, by Distribution Channel

9. Global IBD (Ulcerative Colitis and Crohn’s Disease) Treatment Market Analysis and Forecasts, by Region

9.1. Key Findings

9.2. Global Market Scenario

9.3. Market Value (US$ Mn) Forecast, by Region, 2019-2027

9.4. Market Attractiveness Analysis, by Region

10. North America IBD (Ulcerative Colitis and Crohn’s Disease) Treatment Market Analysis and Forecast

10.1. Key Findings

10.2. Market Value (US$ Mn) Forecast, by Country, 2019-2027

10.3. Market Value (US$ Mn) Forecast, by Drug Class, 2019-2027

10.4. Market Value (US$ Mn) Forecast, by Disease Indication, 2019-2027

10.5. Market Value (US$ Mn) Forecast, by Distribution Channel, 2019-2027

10.6. Market Attractiveness Analysis

11. Europe IBD (Ulcerative Colitis and Crohn’s Disease) Treatment Market Analysis and Forecast

12. Asia Pacific IBD (Ulcerative Colitis and Crohn’s Disease) Treatment Market Analysis and Forecast

13. Latin America IBD (Ulcerative Colitis and Crohn’s Disease) Treatment Market Analysis and Forecast

14. Middle East and Africa IBD (Ulcerative Colitis and Crohn’s Disease) Treatment Market Analysis and Forecast

15. Competition Landscape

15.1. Global IBD (Ulcerative Colitis and Crohn’s Disease) Treatment Market Share, by Company, 2018

15.2. Market Player - Competition Matrix (By Tier and Size of companies)

15.3. Company Profiles (Details - Overview, Financials, Recent Developments, Strategy)

15.3.1. Pfizer, Inc.

15.3.2. Janssen Biotech, Inc. (Johnson & Johnson)

15.3.3. Valeant Pharmaceuticals International, Inc.

15.3.4. Allergan plc.

15.3.5. Takeda Pharmaceutical Company Limited.

15.3.6. AbbVie, Inc.

15.3.7. Novartis AG

15.3.8. UCB Inc.

15.3.9. Biogen Inc.

For more information about this report visit https://www.researchandmarkets.com/r/adkmgd

View source version on businesswire.com:https://www.businesswire.com/news/home/20200212005706/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2020.

PUB: 02/12/2020 12:56 PM/DISC: 02/12/2020 12:56 PM

http://www.businesswire.com/news/home/20200212005706/en